# GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

> **NCT00567424** · PHASE2 · WITHDRAWN · sponsor: **GlaxoSmithKline**

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** GW273225

## Key facts

- **NCT ID:** NCT00567424
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-07
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No longer viable
- **Last updated:** 2013-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00567424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00567424, "GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00567424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*